Fujian Cosunter Pharmaceutical Co., Ltd.
SHZ: 300436.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Guoping Li
- Employees
- 908
- Headquarters
- Fuzhou, China
- IPO year
- 2015
- Market cap
- CN¥18.4B
- Website
- https://www.cosunter.com
Loading 300436…
Loading profile data…Frequently asked questions about 300436
What does Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) do?
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers Chinese patent medicines in the areas of liver diseases, andrology, cardiovascular, and other fields. The company was founded in 2001 and is based in Fuzhou, China.
Where does 300436.SZ trade?
Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300436.SZ in?
Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Fujian Cosunter Pharmaceutical Co., Ltd.?
Guoping Li is the chief executive officer of Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ).
Where is Fujian Cosunter Pharmaceutical Co., Ltd. headquartered?
Fujian Cosunter Pharmaceutical Co., Ltd. is headquartered in China.
Does 300436.SZ pay a dividend?
Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 300436.SZ go public?
Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) completed its initial public offering in 2015.